oakey, I don't think ABID did any due diligence for their valuations. It seems as though their only source of information was EHR. Unrealistic is the word that comes to mind. With a PPA and some funding, I see the share price recovering to between 4c and 5c with current SOI. If Torey wants his 40m performance options, he is going to have to work very hard to get the sp over 7c. Of course, a positive result from the troubled Fiale project would do the trick, but I doubt that's going to happen.
PT, I'm also invested in PAX which makes the parallels between EHR and PAX very depressing for me. We certainly need a success story in the ASX listed geothermal sector because this could lead to a renewed interest from investors more broadly. The problem is, these companies need enough funds to make it through to commissioning. This means that capital raisings (and dilution) are a necessary evil and that will keep most investors on the sidelines.
EHR Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held
